Ulcerative colitis: open trials in Spain

26 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Juan Ramon Jimenez, Huelva · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario La Paz, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital General De Tomelloso, Tomelloso · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-05
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Centro Médico Teknon, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Arquitecto Marcide, Ferrol · Hospital de Cabuenes, Gijón · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Central De Asturias, Oviedo · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Virgen Macarena, Seville · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-11-04
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Centro Médico Teknon, Barcelona · Hospital Universitario de Fuenlabrada, Fuenlabrada · Hospital de Cabuenes, Gijón · Hospital Universitario La Paz, Madrid
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario Infanta Leonor, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Complexo Hospitalario Universitario De Vigo, Vigo · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Hospital Universitario de Cabueñes, Gijón · Hospital Universitario Lucus Augusti, Lugo · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Complejo Hospitalario Universitario de Ourense, Ourense · Clínica Gaias - Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-03
NCT07848737
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
Research · Janssen-Cilag, S.A.
Hosp. Clinico Univ. de Santiago, Santiago de Compostela
Registry updated 2026-11-03
2025-522362-78-00
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Trial Treatment · Phase 4 · Eli Lilly & Co.
Hospital Universitario La Paz, Madrid
Registry updated 2026-10-30
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Barcelona · Valencia
Registry updated 2026-10-30
NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Trial Treatment · Phase 2 · Pfizer
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Parc Tauli Hospital Universitari, Sabadell · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela
Registry updated 2026-10-27
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Hospital Universitario de Cabueñes, Gijón · Hospital Universitario Lucus Augusti, Lugo · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Complejo Hospitalario Universitario de Ourense, Ourense · Clínica Gaias - Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-10-27
NCT07071519
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Trial Treatment · Phase 3 · AbbVie
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda
Registry updated 2026-10-27
2024-511458-32-00
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Hospital Germans Trias i Pujol, Badalona · Hospital Universitario Reina Sofia, Córdoba
Registry updated 2026-10-26
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Badalona · Esplugues de Llobregat · Madrid · Madrid · Madrid
Registry updated 2026-10-20
NCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Hospital Germans Trias i Pujol, Badalona · Hospital Universitario Reina Sofia, Córdoba
Registry updated 2026-10-20
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Huelva
Registry updated 2026-10-16
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Area Sanitaria De Ferrol, Ferrol · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-09
2025-522338-30-00
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Trial Treatment · Phase 2 · Eli Lilly & Co.
Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitario de Fuenlabrada, Fuenlabrada · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario La Paz, Madrid · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife
Registry updated 2026-10-07
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario Reina Sofia, Córdoba · Hospital Sant Joan De Deu, Esplugues de Llobregat · Hospital Universitari Parc Taulí, Sabadell · Hospital Universitari i Politécnic La Fe, Valencia
Registry updated 2026-10-07
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Area Sanitaria De Ferrol, Ferrol · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-08-03
2023-509248-86-00
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb Services Unlimited Company
Hospital Germans Trias i Pujol, Badalona · Sant Joan De Deu Barcelona Hospital, Esplugues De Llobregat · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital General Universitario Gregorio Marañón, Madrid
Registry updated 2026-07-22
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Hospital Sant Joan de Deu - PIN, Barcelona · Hospital Infantil Universitario Niño Jesus - PIN, Madrid · Hospital Regional Universitario de Malaga - Hospital Materno-Infantil, Málaga · Hospital de Sagunto, Sagunto · Hospital Universitario Virgen del Rocio - PPDS, Seville
Registry updated 2026-05-07
NCT05698745
Immunological Characteristics of Preclinical IBD
Research · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Hospital General Universitario Dr. Balmis, Alicante · Hospital Universitario Germans Trias i Pujol, Badalona · Hospital de Sant Joan Despí - Moises Broggi, Barcelona · Hospital Universitario de Basurto, Bilbao · Hospital Universitario De Burgos, Burgos · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Donostia, Donostia / San Sebastian · Hospital Universitario de Galdakao, Galdakao · Hospital Universitario de Cabueñes, Gijón · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario de la Princesa, Madrid · ALTHAIA, Xarxa Assistencial Universitaria de Manresa., Manresa · Complejo Hospitalario Universitario de Ourense, Ourense · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario de Canarias, San Cristóbal de La Laguna · Hospital Clínico Universitario de Santiago, Santiago de Compostela · Hospital Universitari Mútua de Terrassa, Terrassa · Hospital Univeristario y Politécnico La Fe, Valencia · Hospital Universitario Clínico de Valencia, Valencia · Hospital Universitario Rio Hortega, Valladolid · Hospital Álvaro Cunqueiro (Complejo Hospitalario Universitario de Vigo), Vigo · Hospital Clinico Universitario Lozano Blesa, Zaragoza · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-04-15
NCT07248644
Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
Trial Treatment · Phase 4 · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Hospital Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario La Paz, Madrid · Consorci Sanitari Del Maresme, Mataro · Hospital Santa Ana, Motril · Complejo Hospitalario Universitario de Ourense, Ourense · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Fundacio Assistencial De Mutua De Terrassa Fpc, Terrassa · Hospital Alvaro Cunqueiro, Vigo · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-04-15
NCT07347158
Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
Trial Treatment · Hospital Clinico Universitario de Santiago
Complejo Hospitalario Universitario De Santiago De Compostela, Santiago de Compostela
Registry updated 2026-01-16

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error